Recent evidence reveals that psychedelics seem to be helpful for the treatment of several mental health conditions. Specifically, clinical findings show that psilocybin, MDMA, LSD, ayahuasca, ibogaine, and ketamine may be effective in treating post-traumatic stress disorder (PTSD), generalized anxiety disorder, depression, alcohol and substance use disorder, and obsessive-compulsive disorder. MDMA ("ecstasy") will most likely be the first psychedelic to undergo evaluation for full FDA approval (for treatment of PTSD) and DEA rescheduling.
Speaker: Jennifer Mitchell, UC San Francisco
Note corrected time
Contact:Website: Click to Visit
Save this Event:iCalendar
Windows Live Calendar
Novato, CA 94945
Website: Click to Visit